TerminatedPhase 4

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

Stopped: study terminated 12Feb09 due to low recruitment

Canada68 participantsStarted 2005-02

Plain-language summary

In order to distinguish between clonal instability driven by imatinib in CML and actual changes with secondary clones induced by imatinib we would like to investigate the karyotype of non-CML patients treated with imatinib such as GIST patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * GIST patient on Imatinib for more than 12 months Exclusion Criteria: * nil

What they're measuring

~ presence or absence of genetic abnormality as seen in CML patients on imatinib

Trial details

NCT IDNCT00461929

SponsorUniversity Health Network, Toronto

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-12

View on ClinicalTrials.gov More Chronic Myeloid Leukemia trials